Skip to main content
    P

    Phio Pharmaceuticals Corp (PHIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.75
    -0.02 (-2.44%)

    Market Cap: $9.21M

    Last updated: Nov 17, 2026 at 11:00 AM ET

    Phio Pharmaceuticals Corp (PHIO) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Phio Pharmaceuticals (PHIO) to earn -$1.45 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.61.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss.

    Fiscal year ending Dec 31, 2026
    -$1.45
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$0.61
    EPS consensus
    Next report
    Mar 3, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$1.45-$1.47 to -$1.422
    Dec 31, 2027-$0.61-$0.77 to -$0.452

    Quarterly Estimates

    The EPS consensus rises from -$0.39 for the quarter ending Dec 31, 2026 to -$0.13 for the quarter ending Mar 31, 2027.

    EPS range

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.39-$0.39 to -$0.394
    Mar 31, 2027-$0.13-$0.13 to -$0.131

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 2 upward and 3 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202602
    Fiscal year ending Dec 31, 202720
    Quarter ending Mar 31, 202701

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$1.38.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$1.45-$1.45-$1.45-$1.45-$1.38N/A
    Fiscal year ending Dec 31, 2027-$0.61-$0.61-$0.61-$0.61-$0.86N/A
    Quarter ending Mar 31, 2027-$0.13-$0.13-$0.13-$0.13-$0.20N/A

    Frequently Asked Questions About PHIO

    What is the PHIO stock forecast?

    Consensus analyst estimates put Phio Pharmaceuticals's EPS at -$1.45 for the fiscal year ending Dec 31, 2026.

    What EPS do analysts expect from PHIO next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.45, with estimates from -$1.47 to -$1.42 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.61, with estimates from -$0.77 to -$0.45 from 2 analysts.

    How many analysts cover PHIO?

    2 analysts estimate EPS for Phio Pharmaceuticals for the fiscal year ending Dec 31, 2026.